The high-dose,
low-frequency interferon

Find out if PLEGRIDY could be right for your relapsing MS patients.


The ADVANCE clinical trial examined 3 key measures of disease activity

Review the data
Safety and tolerability1

Review the well-established safety profile and strategies to address tolerability

See safety
26 injections per year1

Find out if dosing with PLEGRIDY may fit into your patient’s routine

Explore dosing and administration

Start your patients on treatment

Download Start Form
Streamline your process and support patient adherence

myBiogen is an online resource for starting and keeping patients on therapy

Register today